Marshall Edwards
 
   
About Phenoxodiol

Frequently asked questions

  About Phenoxodiol
Phenoxodiol has been developed as a therapy for
  • early-stage prostate cancer
  • late-stage, hormone-refractory prostate cancer
  • early stage cervical and vaginal cancer
  • chemo-resistant and chemo-refractory ovarian cancer.

Phenoxodiol is a broad-spectrum anti-cancer drug that induces cancer cell death through inhibition of anti-apoptotic proteins including XIAP and FLIPshort.

The mechanism of action of phenoxodiol suggests its potential to be used both as a monotherapy and in combination with standard anti-cancer drugs where it acts to enhance the efficacy of those drugs in chemo-sensitive patients and to restore sensitivity to those drugs in chemo-resistant patients.



 
Contact Details
 
Marshall Edwards, Inc.
11975 El Camino Real
Suite 101
San Diego, CA 92130

T: (858) 792-6300

email
about Phenoxodiol
.

 

home : about us. : about phenoxodiol : the technology : newsroom :
: how to invest : contact details : credits : email

Marshall Edwards Inc. 2001 ©